This demands additional supplements to improve exercise performance
Biological actions of GLP-1, source: reference [1] Evolution of GLP1 GLP-1RAs Currently, there are nine GLP-1RAs approved for marketing worldwide (Table 1), mainly for the treatment of diabetes and obesity, of which tirzepatide is a novel dual GLP-1RA/GIPR agonist
BPC-157Also known as: Body Protective Compound 157, BPC157, Bepecin, Pentadecapeptide BPC 157 Mechanism of Action BPC-157 (Body Protective Compound 157) is a synthetic pentadecapeptide derived from a protein sequence found in human gastric juice
Until human clinical trials provide definitive answers, BPC-157 remains a fascinating but incompletely understood compound with promising preclinical support
Some are, but with limitations: Liraglutide (Saxenda) is approved for weight management in adolescents aged 12-17 with obesity and a body weight above 132 pounds